Estrigenix Therapeutics

Founded in 2018, Estrigenix Therapeutics is a privately held pharmaceutical company dedicated to developing innovative therapies aimed at improving the mental and physical health of menopausal women. The company's core mission is to leverage applied and original estrogen-based research to create targeted chemistry solutions that significantly alleviate the symptoms associated with menopause. Estrigenix focuses on pioneering next-generation therapeutics to enhance women's health, with an emphasis on mental well-being during menopause.

Estrigenix Therapeutics has attracted notable investors and experts in the field of women's health and pharmaceutical development. The company has made significant strides in its research and development efforts, positioning itself as a leader in the niche market of menopausal health. Through its groundbreaking work, Estrigenix has had a meaningful impact on the quality of life for menopausal women, offering promising new treatments that address both mental and physical symptoms.